| Product Code: ETC12465199 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Israel continues to rely on a diverse range of countries for its immunomodulators imports, with Switzerland, UK, Belgium, USA, and Germany leading the way. The low concentration of the Herfindahl-Hirschman Index (HHI) indicates a competitive market landscape. However, the compound annual growth rate (CAGR) from 2020 to 2024 shows a slight decline at -2.14%, with a further decrease in growth rate from 2023 to 2024 at -0.41%. This suggests a challenging environment for immunomodulators importers in Israel, potentially impacted by various factors influencing the market dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Immunomodulators Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Immunomodulators Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Immunomodulators Market - Industry Life Cycle |
3.4 Israel Immunomodulators Market - Porter's Five Forces |
3.5 Israel Immunomodulators Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Immunomodulators Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Immunomodulators Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Israel Immunomodulators Market Revenues & Volume Share, By Mode of Action, 2021 & 2031F |
3.9 Israel Immunomodulators Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
4 Israel Immunomodulators Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in Israel |
4.2.2 Growing adoption of advanced immunomodulatory therapies |
4.2.3 Rising healthcare expenditure in the country |
4.3 Market Restraints |
4.3.1 Stringent regulations governing the approval and commercialization of immunomodulators |
4.3.2 High costs associated with immunomodulatory treatments |
4.3.3 Limited awareness about immunomodulators among healthcare providers and patients |
5 Israel Immunomodulators Market Trends |
6 Israel Immunomodulators Market, By Types |
6.1 Israel Immunomodulators Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Immunomodulators Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Israel Immunomodulators Market Revenues & Volume, By Immunosuppressants, 2021 - 2031F |
6.1.4 Israel Immunomodulators Market Revenues & Volume, By Immunostimulants, 2021 - 2031F |
6.1.5 Israel Immunomodulators Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.6 Israel Immunomodulators Market Revenues & Volume, By Peptide-Based Immunomodulators, 2021 - 2031F |
6.1.7 Israel Immunomodulators Market Revenues & Volume, By Small Molecule Immunomodulators, 2021 - 2031F |
6.2 Israel Immunomodulators Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Immunomodulators Market Revenues & Volume, By Organ Transplantation, 2021 - 2031F |
6.2.3 Israel Immunomodulators Market Revenues & Volume, By Cancer Treatment, 2021 - 2031F |
6.2.4 Israel Immunomodulators Market Revenues & Volume, By Autoimmune Disorders, 2021 - 2031F |
6.2.5 Israel Immunomodulators Market Revenues & Volume, By Infectious Disease Treatment, 2021 - 2031F |
6.2.6 Israel Immunomodulators Market Revenues & Volume, By Allergy Management, 2021 - 2031F |
6.3 Israel Immunomodulators Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Immunomodulators Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel Immunomodulators Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.4 Israel Immunomodulators Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.5 Israel Immunomodulators Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.3.6 Israel Immunomodulators Market Revenues & Volume, By Public Health Organizations, 2021 - 2031F |
6.4 Israel Immunomodulators Market, By Mode of Action |
6.4.1 Overview and Analysis |
6.4.2 Israel Immunomodulators Market Revenues & Volume, By T-Cell Suppression, 2021 - 2031F |
6.4.3 Israel Immunomodulators Market Revenues & Volume, By Cytokine Activation, 2021 - 2031F |
6.4.4 Israel Immunomodulators Market Revenues & Volume, By Antibody Blocking, 2021 - 2031F |
6.4.5 Israel Immunomodulators Market Revenues & Volume, By Immune Response Modulation, 2021 - 2031F |
6.4.6 Israel Immunomodulators Market Revenues & Volume, By Signal Transduction Blocking, 2021 - 2031F |
6.5 Israel Immunomodulators Market, By Sales Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Immunomodulators Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
6.5.3 Israel Immunomodulators Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.5.4 Israel Immunomodulators Market Revenues & Volume, By Wholesale Suppliers, 2021 - 2031F |
6.5.5 Israel Immunomodulators Market Revenues & Volume, By Government Procurement, 2021 - 2031F |
6.5.6 Israel Immunomodulators Market Revenues & Volume, By Hospital Contracts, 2021 - 2031F |
7 Israel Immunomodulators Market Import-Export Trade Statistics |
7.1 Israel Immunomodulators Market Export to Major Countries |
7.2 Israel Immunomodulators Market Imports from Major Countries |
8 Israel Immunomodulators Market Key Performance Indicators |
8.1 Average time to market approval for new immunomodulators |
8.2 Number of clinical trials evaluating immunomodulatory therapies in Israel |
8.3 Patient adherence rates to immunomodulatory treatments |
8.4 Percentage of healthcare providers trained in prescribing immunomodulators |
8.5 Rate of adoption of immunomodulatory therapies in different regions of Israel |
9 Israel Immunomodulators Market - Opportunity Assessment |
9.1 Israel Immunomodulators Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Immunomodulators Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Immunomodulators Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Israel Immunomodulators Market Opportunity Assessment, By Mode of Action, 2021 & 2031F |
9.5 Israel Immunomodulators Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
10 Israel Immunomodulators Market - Competitive Landscape |
10.1 Israel Immunomodulators Market Revenue Share, By Companies, 2024 |
10.2 Israel Immunomodulators Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here